Sven Markert is currently the Global Head of Cell Culture Development for Gene Therapy at Genentech, having previously held the same role at Roche from 2019 to 2022. They led global teams in the development and commercialization of gene therapy products, overseeing critical processes from pre-clinical stages to market approval. Sven earned a PhD in Technical Chemistry from TCI Hannover and is continuing their education at Universität Bielefeld. Their extensive experience includes leadership roles in technical development and project management within the biotechnology industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices